Neurosense Therapeutics
Price & Volume
Stats
See moreOpen | $1.33 |
Previous Close | $1.28 |
Day Range | $1.31-$1.45 |
52W Range | $1.10-$25.40 |
Market Cap | $2.7M |
Shares Short | 26,105 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$47.10 |
News
See moreYahoo Finance • 23 days ago
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
Yahoo Finance • last month
NeuroSense Provides Update on Nasdaq Listing Compliance
Yahoo Finance • 7 months ago
NeuroSense Therapeutics receives Nasdaq notices over listing requirements
About
CEO | Mr. Alon Ben-Noon |
Address | Building B, Herzliya, Israel, 4672562 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |